About Us

The Company

Palo Alto Health Sciences, Inc. is a privately held Silicon Valley digital therapeutic company at the forefront of revolutionizing behavioral healthcare with evidence based, at-home, drug-free solutions. Our product, Freespira®, is an FDA-cleared treatment for individuals suffering from panic disorder, panic attacks and other symptoms of panic.

Our Mission

To improve quality-of-life of people suffering from debilitating panic attacks and anxiety disorders, reduce medical costs, and support the appropriate utilization of valuable healthcare resources.

Press Releases

Multiple Studies Show Freespira® Eliminates Panic Attacks in 80% of Patients

April 11, 2018 | News

50% Reduction in Health Costs One Year Post-Treatment Also Demonstrated Danville, CA – (April 11 , 2018) – Palo Alto Health …

Palo Alto Health Sciences Accelerates Commercialization of Freespira®

March 14, 2018 | News

Palo Alto Health Sciences Accelerates Commercialization of Freespira® Company is expanding focus on bridging mental and physical health in employer and …

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks

November 28, 2017 | News

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks At 12 months post-treatment, participants’ total medical costs reduced …

Palo Alto Health Sciences Names Amy Perry to Board of Directors

August 17, 2017 | News

Danville, CA – (August 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic …

Freespira® Clinical Data to be Presented at Three Upcoming Conferences

May 17, 2017 | News

Danville, CA – (May 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for …

Palo Alto Health Sciences Partners with Silicon Valley TMS Integrated Clinical Neurosciences to Offer Freespira® Treatment for Panic Attacks and Panic Disorder

May 2, 2017 | News

Danville, CA – (May 2, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic …

Next Generation Freespira® System for Panic Attacks to be Unveiled at Anxiety and Depression Association of America Conference

April 4, 2017 | News

Danville, CA – (April 4, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for …

New Freespira® Study Shows Nearly 80% of Patients are Panic Attack Free at One Year Post-Treatment

February 22, 2017 | News

The drug-free, four-week at-home treatment produces lasting results Danville, CA – (February 22, 2017) – Palo Alto Health Sciences, Inc. (PAHS), …

Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting

February 17, 2017 | News

Danville, CA – (May 15, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of Freespira®, the only FDA-cleared digital …

Freespira In the News

Panic sufferers take life back from grip of fear: Pittsburgh Post-Gazette, January 2018

Study finds breathing device treats panic attacks – and lowers medical costs: Philadelphia Inquirer, November 2017

Highmark Health’s VITAL Innovation Program Validates Effective Drug-Free Treatment for Panic Attacks: Highmark Health, November 2017

Time to Stop Panicking!: Psychology Today, May 2016

The secret to wellbeing: learning to breathe properly: The Telegraph UK, January 2016

Re-Learning to Breathe With Freespira Can Ease Panic Symptoms: Highmark Health Blog, March 2015

A new way to banish panic attacks: ABC 7 Chicago, March 2016

New medical device helps with panic attacks: ABC 7 Los Angeles, April 2016